• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋多糖在药物应用中的作用:褐藻糖胶和壳聚糖作为药物传递领域的关键角色。

Marine Polysaccharides in Pharmaceutical Applications: Fucoidan and Chitosan as Key Players in the Drug Delivery Match Field.

机构信息

LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Portugal, Rua de Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.

出版信息

Mar Drugs. 2019 Nov 21;17(12):654. doi: 10.3390/md17120654.

DOI:10.3390/md17120654
PMID:31766498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6950187/
Abstract

The use of marine-origin polysaccharides has increased in recent research because they are abundant, cheap, biocompatible, and biodegradable. These features motivate their application in nanotechnology as drug delivery systems; in tissue engineering, cancer therapy, or wound dressing; in biosensors; and even water treatment. Given the physicochemical and bioactive properties of fucoidan and chitosan, a wide range of nanostructures has been developed with these polysaccharides per se and in combination. This review provides an outline of these marine polysaccharides, including their sources, chemical structure, biological properties, and nanomedicine applications; their combination as nanoparticles with descriptions of the most commonly used production methods; and their physicochemical and biological properties applied to the design of nanoparticles to deliver several classes of compounds. A final section gives a brief overview of some biomedical applications of fucoidan and chitosan for tissue engineering and wound healing.

摘要

近年来,由于海洋来源多糖具有丰富、廉价、生物相容和可生物降解等特点,其在科研中的应用日益增多。这些特性促使它们在纳米技术中作为药物传递系统;在组织工程、癌症治疗或伤口敷料;在生物传感器中;甚至在水处理中得到应用。鉴于褐藻糖胶和壳聚糖的物理化学和生物活性特性,已经用这些多糖本身和它们的组合开发了广泛的纳米结构。本文综述了这些海洋多糖,包括它们的来源、化学结构、生物特性和纳米医学应用;它们与纳米粒子结合的描述,以及最常用的生产方法;以及它们的物理化学和生物学特性在设计用于传递几类化合物的纳米粒子中的应用。最后一节简要概述了褐藻糖胶和壳聚糖在组织工程和伤口愈合方面的一些生物医学应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/bb0855aa6f22/marinedrugs-17-00654-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/235acd696a45/marinedrugs-17-00654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/7969148e13db/marinedrugs-17-00654-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/9c0809969f26/marinedrugs-17-00654-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/124d013d12d0/marinedrugs-17-00654-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/29dca358cee0/marinedrugs-17-00654-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/bb0855aa6f22/marinedrugs-17-00654-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/235acd696a45/marinedrugs-17-00654-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/7969148e13db/marinedrugs-17-00654-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/9c0809969f26/marinedrugs-17-00654-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/124d013d12d0/marinedrugs-17-00654-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/29dca358cee0/marinedrugs-17-00654-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/807e/6950187/bb0855aa6f22/marinedrugs-17-00654-g006.jpg

相似文献

1
Marine Polysaccharides in Pharmaceutical Applications: Fucoidan and Chitosan as Key Players in the Drug Delivery Match Field.海洋多糖在药物应用中的作用:褐藻糖胶和壳聚糖作为药物传递领域的关键角色。
Mar Drugs. 2019 Nov 21;17(12):654. doi: 10.3390/md17120654.
2
Marine polysaccharide-based nanomaterials as a novel source of nanobiotechnological applications.基于海洋多糖的纳米材料作为纳米生物技术应用的新型来源。
Int J Biol Macromol. 2016 Jan;82:315-27. doi: 10.1016/j.ijbiomac.2015.10.081. Epub 2015 Oct 30.
3
Marine polysaccharides: therapeutic efficacy and biomedical applications.海洋多糖:治疗功效与生物医学应用。
Arch Pharm Res. 2017 Sep;40(9):1006-1020. doi: 10.1007/s12272-017-0958-2. Epub 2017 Sep 16.
4
Marine polysaccharide-based composite hydrogels containing fucoidan: Preparation, physicochemical characterization, and biocompatible evaluation.含岩藻依聚糖的海洋多糖基复合水凝胶:制备、理化特性及生物相容性评价
Int J Biol Macromol. 2021 Jul 31;183:1978-1986. doi: 10.1016/j.ijbiomac.2021.05.190. Epub 2021 Jun 1.
5
Auto-associative amphiphilic polysaccharides as drug delivery systems.自组装两亲性多糖作为药物传递系统。
Drug Discov Today. 2012 Jun;17(11-12):608-14. doi: 10.1016/j.drudis.2012.01.016. Epub 2012 Jan 25.
6
Application of pH-Responsive Fucoidan/Chitosan Nanoparticles to Improve Oral Quercetin Delivery.pH 响应性褐藻糖胶/壳聚糖纳米粒在提高槲皮素口服传递中的应用。
Molecules. 2019 Jan 18;24(2):346. doi: 10.3390/molecules24020346.
7
Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.由精氨酸修饰壳聚糖和巯基化褐藻糖胶制备的多功能纳米粒用于口服递送疏水性和亲水性药物。
Carbohydr Polym. 2018 Aug 1;193:163-172. doi: 10.1016/j.carbpol.2018.03.080. Epub 2018 Mar 29.
8
Marine Polysaccharides as a Versatile Biomass for the Construction of Nano Drug Delivery Systems.海洋多糖作为一种多功能生物质用于构建纳米药物传递系统。
Mar Drugs. 2021 Jun 16;19(6):345. doi: 10.3390/md19060345.
9
Marine polysaccharides in pharmaceutical applications: an overview.海洋多糖在药物应用中的研究进展:综述
Mar Drugs. 2010 Sep 2;8(9):2435-65. doi: 10.3390/md8092435.
10
Chemical Functionalization of Polysaccharides-Towards Biocompatible Hydrogels for Biomedical Applications.多糖的化学功能化——用于生物医学应用的生物相容水凝胶。
Chemistry. 2018 Jan 26;24(6):1231-1240. doi: 10.1002/chem.201701906. Epub 2017 Nov 3.

引用本文的文献

1
Marine-Derived Polymers-Polysaccharides as Promising Natural Therapeutics for Atherosclerotic Cardiovascular Disease.海洋来源的聚合物——多糖作为动脉粥样硬化性心血管疾病有前景的天然治疗剂
Mar Drugs. 2025 Aug 12;23(8):325. doi: 10.3390/md23080325.
2
Marine-Derived Compounds Combined with Nanoparticles: A Focus on the Biomedical and Pharmaceutical Sector.海洋衍生化合物与纳米颗粒的结合:聚焦生物医学与制药领域
Mar Drugs. 2025 May 13;23(5):207. doi: 10.3390/md23050207.
3
Marine Algae Polysaccharides: An Overview of Characterization Techniques for Structural and Molecular Elucidation.

本文引用的文献

1
Evaluation of the Immunomodulatory Effects of Fucoidan Derived from Tokida in Mice.评估来自 Tokida 的褐藻糖胶对小鼠的免疫调节作用。
Mar Drugs. 2019 Sep 24;17(10):547. doi: 10.3390/md17100547.
2
Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan-Fucoidan Nanoparticles.基于产氧化剂药物负载壳聚糖-褐藻糖胶纳米粒子的选择性抗肿瘤疗法。
Int J Mol Sci. 2019 Jun 30;20(13):3220. doi: 10.3390/ijms20133220.
3
Markers of Systemic Inflammation in Experimental Dyslipidemia Induced by P-407: Modulation with Fucoidan from Brown Alga Fucus evanescens.
海洋藻类多糖:结构与分子解析表征技术综述
Mar Drugs. 2025 Feb 27;23(3):105. doi: 10.3390/md23030105.
4
Antioxidant and anticancer properties of fucoidan isolated from Saccharina Japonica brown algae.从海带属褐藻中分离出的岩藻依聚糖的抗氧化和抗癌特性。
Sci Rep. 2025 Mar 15;15(1):8962. doi: 10.1038/s41598-025-94312-7.
5
Green Nanotechnology: Naturally Sourced Nanoparticles as Antibiofilm and Antivirulence Agents Against Infectious Diseases.绿色纳米技术:天然来源的纳米颗粒作为抗生物膜和抗毒力因子对抗传染病
Int J Microbiol. 2025 Feb 24;2025:8746754. doi: 10.1155/ijm/8746754. eCollection 2025.
6
New Insights into Antiviral Natural Formulations: Biopolymeric Films for the Prevention and Treatment of a Wide Gamma of Viral Infections.抗病毒天然制剂的新见解:用于预防和治疗多种病毒感染的生物聚合物薄膜
Viruses. 2025 Feb 1;17(2):216. doi: 10.3390/v17020216.
7
Marine life as a source of anti-prostate cancer agents: an updated overview (2003-2023).海洋生物作为抗前列腺癌药物的来源:最新综述(2003 - 2023年)
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 20. doi: 10.1007/s00210-025-03886-6.
8
Marine-Derived Polysaccharide Hydrogels as Delivery Platforms for Natural Bioactive Compounds.海洋来源的多糖水凝胶作为天然生物活性化合物的递送平台
Int J Mol Sci. 2025 Jan 17;26(2):764. doi: 10.3390/ijms26020764.
9
Compounds of Marine Origin with Possible Applications as Healing Agents.具有作为治疗剂潜在应用的海洋来源化合物。
Mar Drugs. 2024 Dec 26;23(1):5. doi: 10.3390/md23010005.
10
Unveiling the nutritional and antioxidant properties of brown algae resources ( J.V. Lamouroux) from the Bay of Bengal and Arabian Sea, Indian coast.揭示来自印度海岸孟加拉湾和阿拉伯海的褐藻资源(J.V. 拉穆鲁)的营养和抗氧化特性。
Heliyon. 2024 Dec 8;11(1):e40693. doi: 10.1016/j.heliyon.2024.e40693. eCollection 2025 Jan 15.
P-407诱导的实验性血脂异常中全身炎症标志物:来自褐藻墨角藻的岩藻聚糖的调节作用
Bull Exp Biol Med. 2019 Apr;166(6):766-769. doi: 10.1007/s10517-019-04436-w. Epub 2019 Apr 26.
4
Soluble eggshell membrane protein-loaded chitosan/fucoidan nanoparticles for treatment of defective intestinal epithelial cells.载有可溶性蛋壳膜蛋白的壳聚糖/褐藻糖胶纳米粒治疗有缺陷的肠上皮细胞。
Int J Biol Macromol. 2019 Jun 15;131:949-958. doi: 10.1016/j.ijbiomac.2019.03.113. Epub 2019 Mar 22.
5
Chitosan/fucoidan multilayer coating of gold nanorods as highly efficient near-infrared photothermal agents for cancer therapy.壳聚糖/褐藻糖胶多层金纳米棒涂层作为高效的近红外光热治疗剂用于癌症治疗。
Carbohydr Polym. 2019 May 1;211:360-369. doi: 10.1016/j.carbpol.2019.01.010. Epub 2019 Jan 4.
6
Development of genipin-crosslinked and fucoidan-adsorbed nano-hydroxyapatite/hydroxypropyl chitosan composite scaffolds for bone tissue engineering.用于骨组织工程的京尼平交联和褐藻酸钠吸附纳米羟基磷灰石/羟丙基壳聚糖复合支架的研制。
Int J Biol Macromol. 2019 May 1;128:973-984. doi: 10.1016/j.ijbiomac.2019.02.010. Epub 2019 Feb 8.
7
Application of pH-Responsive Fucoidan/Chitosan Nanoparticles to Improve Oral Quercetin Delivery.pH 响应性褐藻糖胶/壳聚糖纳米粒在提高槲皮素口服传递中的应用。
Molecules. 2019 Jan 18;24(2):346. doi: 10.3390/molecules24020346.
8
Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.由三甲基壳聚糖和岩藻聚糖自组装而成的多功能纳米粒子的开发用于增强胰岛素的口服递送。
Int J Biol Macromol. 2019 Apr 1;126:141-150. doi: 10.1016/j.ijbiomac.2018.12.182. Epub 2018 Dec 23.
9
Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation.载甲氨蝶呤的岩藻聚糖硫酸酯/壳聚糖纳米粒的抗炎作用及其增强皮肤渗透的研究
Int J Biol Macromol. 2019 Mar 1;124:1115-1122. doi: 10.1016/j.ijbiomac.2018.12.014. Epub 2018 Dec 3.
10
Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells.福聚糖/壳聚糖纳米粒递送的吉西他滨对人乳腺癌细胞的毒性增加。
Nanomedicine (Lond). 2018 Aug;13(16):2037-2050. doi: 10.2217/nnm-2018-0004. Epub 2018 Sep 7.